Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)
Clinical trial NCT07570589 · RECRUITING
Trial details
- NCT number
- NCT07570589
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.